A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).

Approximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Imm...

Full description

Bibliographic Details
Main Authors: Yohan Kim, Kerrie Vaughan, Jason Greenbaum, Bjoern Peters, Mansun Law, Alessandro Sette
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3364976?pdf=render
_version_ 1819070381673152512
author Yohan Kim
Kerrie Vaughan
Jason Greenbaum
Bjoern Peters
Mansun Law
Alessandro Sette
author_facet Yohan Kim
Kerrie Vaughan
Jason Greenbaum
Bjoern Peters
Mansun Law
Alessandro Sette
author_sort Yohan Kim
collection DOAJ
description Approximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Immune Epitope Database (IEDB), a repository of freely accessible immune epitope data, revealed more than 1500 and 1900 distinct T cell and antibody epitopes, respectively. The inventory of all data revealed specific trends in terms of the host and the HCV genotypes from which sequences were derived. Upon further analysis we found that this large number of epitopes reflects overlapping structures, and homologous sequences derived from different HCV isolates. To access and visualize this information we developed a novel strategy that assembles large sets of epitope data, maps them onto reference genomes and displays the frequency of positive responses. Compilation of the HCV immune reactivity from hundreds of different studies, revealed a complex and thorough picture of HCV immune epitope data to date. The results pinpoint areas of more intense reactivity or research activities at the level of antibody, CD4 and CD8 responses for each of the individual HCV proteins. In general, the areas targeted by the different effector immune functions were distinct and antibody reactivity was positively correlated with hydrophilicity, while T cell reactivity correlated with hydrophobicity. At the sequence level, epitopes frequently recognized by both T cell and B cell correlated with low variability, and our analysis thus highlighted areas of potential interest for practical applications. The human reactivity was further analyzed to pinpoint differential patterns of reactivity associated with acute versus chronic infection, to reveal the apparent impact of glycosylation on T cell, but not antibody responses, and to highlight a paucity of studies involved antibody epitopes associated with virus neutralization.
first_indexed 2024-12-21T17:05:02Z
format Article
id doaj.art-73eb477b53e1426c8aca60572be7259c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T17:05:02Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-73eb477b53e1426c8aca60572be7259c2022-12-21T18:56:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3802810.1371/journal.pone.0038028A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).Yohan KimKerrie VaughanJason GreenbaumBjoern PetersMansun LawAlessandro SetteApproximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Immune Epitope Database (IEDB), a repository of freely accessible immune epitope data, revealed more than 1500 and 1900 distinct T cell and antibody epitopes, respectively. The inventory of all data revealed specific trends in terms of the host and the HCV genotypes from which sequences were derived. Upon further analysis we found that this large number of epitopes reflects overlapping structures, and homologous sequences derived from different HCV isolates. To access and visualize this information we developed a novel strategy that assembles large sets of epitope data, maps them onto reference genomes and displays the frequency of positive responses. Compilation of the HCV immune reactivity from hundreds of different studies, revealed a complex and thorough picture of HCV immune epitope data to date. The results pinpoint areas of more intense reactivity or research activities at the level of antibody, CD4 and CD8 responses for each of the individual HCV proteins. In general, the areas targeted by the different effector immune functions were distinct and antibody reactivity was positively correlated with hydrophilicity, while T cell reactivity correlated with hydrophobicity. At the sequence level, epitopes frequently recognized by both T cell and B cell correlated with low variability, and our analysis thus highlighted areas of potential interest for practical applications. The human reactivity was further analyzed to pinpoint differential patterns of reactivity associated with acute versus chronic infection, to reveal the apparent impact of glycosylation on T cell, but not antibody responses, and to highlight a paucity of studies involved antibody epitopes associated with virus neutralization.http://europepmc.org/articles/PMC3364976?pdf=render
spellingShingle Yohan Kim
Kerrie Vaughan
Jason Greenbaum
Bjoern Peters
Mansun Law
Alessandro Sette
A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
PLoS ONE
title A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
title_full A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
title_fullStr A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
title_full_unstemmed A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
title_short A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
title_sort meta analysis of the existing knowledge of immunoreactivity against hepatitis c virus hcv
url http://europepmc.org/articles/PMC3364976?pdf=render
work_keys_str_mv AT yohankim ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT kerrievaughan ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT jasongreenbaum ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT bjoernpeters ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT mansunlaw ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT alessandrosette ametaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT yohankim metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT kerrievaughan metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT jasongreenbaum metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT bjoernpeters metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT mansunlaw metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv
AT alessandrosette metaanalysisoftheexistingknowledgeofimmunoreactivityagainsthepatitiscvirushcv